PT - JOURNAL ARTICLE AU - Blake, Tamara L AU - Robinson, Paul D AU - Deery, Maddison T AU - Wainwright, Claire E AU - Hantos, Zoltan AU - Sly, Peter D TI - Intra-breath oscillometry detects ventilation inhomogeneity in Cystic Fibrosis children AID - 10.1101/2023.11.02.23297971 DP - 2023 Jan 01 TA - medRxiv PG - 2023.11.02.23297971 4099 - http://medrxiv.org/content/early/2023/11/04/2023.11.02.23297971.short 4100 - http://medrxiv.org/content/early/2023/11/04/2023.11.02.23297971.full AB - Background Ventilation inhomogeneity (VI) is measured in patients with Cystic Fibrosis (CF) by lung clearance index (LCI) using the Multiple Breath Washout (MBW). In young children, feasibility is often low within busy clinical settings. Intra-breath oscillometry (IB-OSC) measures respiratory system reactance (Xrs), which is determined by the same physiological principles. Given the high feasibility of IB-OSC in young children (>80%), we aimed to explore whether Xrs variables reflected VI as measured by LCI.Methods Paired measurements of IB-OSC (TremoFLO C-100, 10Hz signal) and Nitrogen (N2) MBW (Exhalyzer D) were performed in 97 children with CF. Abnormal LCI was defined as ≥7.1. IB-OSC Xrs variables at end-expiration (XeE), end-inspiration (XeI), volume-dependence of Xrs (ΔX) and ΔX corrected for tidal volume (ΔX/VT) were compared between those with normal and abnormal LCI. Receiver operator characteristic (ROC) analysis was performed to identify cut-off values to detect abnormal LCI.Results 115 acceptable paired IB-OSC and MBW measurements were achieved by 85 children (male 61%, median age 7.8yrs [25th-75th% 5.8-11.9]). 52 (45%) measurements of LCI were abnormal. All Xrs variables where significantly decreased (more negative) in children with abnormal LCI compared to normal (XeE -2.98v-0.81; XeI -2.10v-1.00; ΔX -0.25v0.12; ΔX/VT -0.54v0.22; all p<0.001). Cut-off values for ΔX and ΔX/VT provided the best sensitivity and specificity for detecting abnormal LCI.Conclusion These results suggest that novel IB-OSC variables can detect abnormal VI as measured by N2 MBW-LCI. This technique may allow us to detect and monitor early changes to lung function in busy CF clinics more easily.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study is funded by a Cystic Fibrosis Foundation Project Grant (SLY18KO) and by the Childrens Hospital Foundation.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics committee of Children's Health Queensland Hospital and Health Service gave ethical approval for this work. Written informed consent was obtained from all parents/guardians or participants if <18 years of age.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors.